Skip to main content

Table 6 Lipid profiles of atherosclerotic patients (AS) and healthy controls (control)

From: Association of the S2 allele of the SstI polymorphism in the apoC3 gene with plasma apoCIII interacts with unfavorable lipid profiles to contribute to atherosclerosis in the Li ethnic group in China

Parameter

AS (n = 316)

Control (n = 312)

t

P-value

FBS (mmol /L)

5.88 ± 1.30**

5.67 ± 0.48

2.795

0.005

TC (mmol /L)

5.08 ± 1.10**

4.77 ± 0.80

4.087

0.000

TG (mmol/L)

1.44 ± 1.01**

1.15 ± 0.66

4.245

0.000

HDL-C (mmol/L)

1.12 ± 0.37**

1.27 ± 0.32

−5.443

0.000

LDL-C (mmol/L)

3.16 ± 0.90**

2.83 ± 0.73

4.984

0.000

ApoAI (g/L)

1.20 ± 0.36**

1.28 ± 0.34

−2.964

0.003

ApoB (g/L)

1.03 ± 0.23**

0.87 ± 0.18

9.418

0.000

ApoAI / ApoB

1.24 ± 0.50**

1.54 ± 0.53

−7.226

0.000

Lp(a) (mg/L)

250.02 ± 183.39

227.80 ± 168.16

1.583

0.114

ApoCIII (mg/dL)

16.36 ± 6.20**

10.95 ± 4.45

12.576

0.000

  1. Data are expressed as mean ± SD. FBS: Fasting blood sugar; TC: Total cholesterol; TG: Triglyceride; HDL-C: High density lipoprotein cholesterol; LDL-C: Low density lipoprotein cholesterol; ApoAI: Lipoprotein AI; ApoB: Lipoprotein B; Lp(a): Lipoprotein a; ApoCIII: Apolipoprotein CIII; ** P < 0.01, atherosclerotic patients versus healthy controls analyzed using t-tests